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C O N T E N T S SMEs and New Technology 
SMEs account for over 9 9 . 8 % of all European businesses. 
They are a key source of future European employment and 
prosperity. 
In terms of how many times it participates in EU funded 
research, the SME sector is now an equal partner with 
large companies, universities and research centres. In the 
Innovation Programme itself, 5 3 % of all projects have 
been led by an SME. 
In the f ield of biotechnology, SMEs' most impor tant 
role may not be as a direct source of employment and 
growth, but as the source of the new technologies which 
are essential to the continuing competitiveness of Europe's 
more mature industries. 
Commercialising biotechnology, page 16. 
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But in biotechnology, as in other fields, young high­
tech companies find it too hard to attract the financial 
backing they need. The l­TEC initiative, and the newly­
established Biotechnology and Finance Forum, represent 
attempts to stimulate improved support from venture capi­
tal for the commercial exploitation of European inventions. 
The JRC's new technology transfer initiative should also 
improve SMEs' access to very advanced research facilities. 
Of course, not all SMEs are technology suppliers. 
A second important group contains the smaller enterprises 
which must exploit, develop and spread the use of new 
technologies, if Europe is to benefit fully from its world­
class research. The ESPRIT programme's HPCN initiative 
offers an excellent example of the way in which the take­
up of new technologies by smaller firms can be successfully 
promoted. 
Edith Cresson 
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POLICY NEWS 
E U R O P E A N SCIENCE AND T E C H N O L O G Y 
Indicate Before 
Overtaking 
How good is Europe's scientific and technological performance? How does 
it compare with the performance of other regions? And how should public 
funding be allocated in order to make technology work for the economy, 
for jobs, and for society as a whole? 
T o help policy­makers an­swer such questions, the 
European Commission has 
produced an updated and en­
hanced edition of its European 
Report on Science and Tech­
nology Indicators O). 
Commissioner Edith Cresson, 
who requested the report, 
stresses that its focus is on 
the priorities of the EU's next 
research framework pro­
grammets) ­ the economic im­
pacts of research and innova­
tion, European and global 
industrial partnerships, and 
employment, training and 
the development of human 
resources. 
Overall, its findings are both 
encouraging and worrying, she 
says. Europe remains the 
world's second scientific pow­
er, and the growth of a Euro­
pean community of companies 
and institutes engaged in 
transnational collaborative 
research has strengthened its 
position. On the other hand, 
Europe is falling behind the 
United States and other com­
petitor regions, both in the 
resources invested in science 
and technology, and in the ef­
ficiency with which these are 
converted into success in the 
marketplace. 
C o u l d D o B e t t e r 
Part I of the report analyses 
the development of EU science 
and technology relative to glob­
al trends, covering non­EU 
countries in Europe and the 
emerging Asian economies as 
Figure 1 
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High­tech products as a percentage of total exports in technology­intensive sectors 
in ¡apan, the US and the EU (excluding Germany) 
well as the US and Japan. 
■ The global economy will in­
creasingly be divided along 
lines determined by access to 
scientific and technological 
knowledge and the ability to 
exploit this knowledge. ' 
■ Both as a percentage of GDP 
and per capita, the EU invests 
less in S&T than the US or 
Japan. 
■ Job creation ­ an area in 
which EU performance relative 
to that of the US and Japan is 
especially weak ­ is stronger in 
countries where information 
and communication technolo­
gies absorb a higher proportion 
of investment. 
■ Europe's science and engi­
neering graduation rates are 
significantly lower than those 
of the Developed Asian Eco­
nomies (DAE) or of the US and 
Canada, and it has a smaller 
percentage of research scien­
tists in its working population, 
especially in the private sector. 
■ EU patent activity remains 
concentrated in established 
fields ­ aerospace, chemicals, 
pharmaceuticals and car man­
ufacturing. Its relative weak­
ness in computers, electronics 
and instruments worsened be­
tween 1993 and 1995. 
■ High­tech products consti­
tute 12% of total EU exports, 
compared with 24% in the US 
and 25% in Japan. Only two 
Member States ­ Sweden and 
the UK ­ achieved an average 
trade surplus in high­tech prod­
ucts in the years 1991 ­95. 
Part II examines the relation­
ships between investment, in­
novation capacity and eco­
nomic performance in coun­
tries, industrial sectors and 
companies, and analyses in­
novation and technological 
competitiveness in multina­
tional companies, in nev tech­
nology based firms (NTBFs), 
and in the SME sector. 
■ Of all research­intensive sec­
tors, EU R&D intensity (R&D/ 
sales) is higher than that of both 
the US and Japan in only one 
­ electronics (see Figure 2). 
■ Europe's failure to convert 
high­quality research into mar­
ketable technologies and prod­
ucts ­ the 'European Paradox' 
­ persists, but not in all coun­
tries and industries. Perfor­
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mance is strongest in Denmark, 
Finland and the Netherlands, 
and in the automotive and 
chemicals sectors. 
■ Despite this, EU high­tech 
exports have grown rapidly 
since 1990, especially in com­
puters and electronics, though 
growth is heavily concentrated 
in the Netherlands and the UK. 
Part III looks at national re­
search and innovation policies 
and systems in the EU Mem­
ber States, and assesses 
progress towards cohesion. 
Europe's non­EU countries are 
also considered, and the 
Mediterranean countries are 
the subject of a special Dossier. 
S o l i d F r a m e w o r k 
Part IV analyses EU research 
and other European­level pub­
lic sector schemes. It also looks 
at technological R&D co­oper­
ation between companies, and 
at mobility and co­operation 
between researchers. 
■ The EU research Framework 
Programmes now constitute a 
key source of R&D funding. In­
cluding the Structural Funds, 
the Commission's share of all 
public investment in EU civil 
R&D has more than doubled 
from 4.6% in 1987­90 to 9.7% 
in 1995­96. 
■ In the past 10 years, partici­
pation in EU shared­cost R&D 
has become progressively 
more equal ­ between large 
firms and SMEs, between in­
dustry and academic re­
searchers, and between Mem­
ber States (see map). 
■ Transnational R&D co­oper­
ation between companies, uni­
versities and research centres 
is now a fundamental and dy­
namic feature of the EU. The 
Framework Programmes have 
been a decisive factor in its de­
velopment, and are leading to 
improved co­ordination of na­
tional and Community R&D 
policies. 
■ Technology­based alliances 
­ and inter­sectoral ones in 
particular ­ are increasingly 
important. Growth in the for­
mation of such alliances in the 
Figure 2 7994 /?&£) spending as a percentage of operating 
revenues in eight manufacturing sectors. 
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Electronics is the only research­intensive sector in which Europe's R&D is higher (as a proportion 
of sales revenues) than that of both the US and japan. 
EU is keeping pace with that in 
the DAE and NAFTA, although 
from a significantly lower base 
than the latter. 
Fits All Pock e ts 
The depth of the analysis ap­
plied to the statistical data re­
flects feedback from the Euro­
pean research community on 
the First European Report on 
S&T Indicators, published in 
1994. But at nearly 750 pages, 
plus 200 pages of annexes, the 
1997 Report is much more 
comprehensive. 
The new edition does include 
a number of further innovations 
which will make it much more 
accessible. The report itself in­
cludes an executive summary, 
and the Commission is also 
producing a pocket­sized com­
pendium of 'Key Figures' and 
an interactive CD­ROM. □ 
Regional distribution of 
participations in shared­
cost research under the 
Fourth Framework 
Programme. 
(1) Second European Report on 
S&T Indicators 1997 (EUR 17639) ­
2 volumes plus CD­ROM ­ price 60 
ECU, only from EUR­OP Sales 
Agents (see Note, page 24). 
(2) The Fifth Framework Program­
me, now in preparation (see Note­
book, page 6). 
C o n t a c t ■ I. Perry, DG XII Fx. +32 2 296 28 40 
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► J O I N T RESEARCH C E N T R E 
Catalytic 
Conversion 
The JRC is the European Commission's own research centre. Now it is 
to launch a series of schemes designed to help industry benefit from its 
facilities and expertise, to stimulate EU-wide collaborative research, 
and to facilitate market exploitation of the technologies which it develops. 
T he European Technology Transfer Initiative, adopt­
ed by the Commission on 7 
January, is the result of a re­
view of the JRC's technology 
transfer potential carried out 
during 1997 in consultation 
with industry. 
The study was originally in­
tended to assess the feasibili­
ty of establishing a European 
technology park on the JRC's 
Ispra site in Italy. More gener­
ally, it sought to identify ways 
to make better use of the JRC's 
human and technical capacity, 
and to forge stronger links with 
European industry, especially 
SMEs. 
The creation of a convention­
al technology park was not, in 
the end, found to be the most 
effective way of achieving these 
objectives. But adding value to 
the JRC's role as the Commis­
sion's research centre, through 
greater practical engagement 
with Europe's industrial and 
academic research communi­
ty, was considered not only 
feasible but indispensable. 
M o r e A c c e s s i b l e 
Instead of a technology park, 
the study recommended a 
package of 'flexible access 
mechanisms', designed to en­
hance the JRC's contribution 
to technology transfer and col­
laborative research, very much 
in line with the Commission's 
Innovation Action PlanO). 
■ First, the JRC will develop a 
scheme to give outside com­
panies supported or collabo­
rative access to its many large 
and sophisticated facilities and 
laboratories. 
■ The establishment of a tech­
nology transfer fund was rec­
ommended, as a source of 
seed capital for the exploitation 
of JRC technologies by small­
er companies, and as a way of 
giving outside investors op­
portunities to participate in 
such projects. 
■ The JRC will create a virtu­
al technology park, develop­
ing and demonstrating an in­
novative 'remote research' 
methodology, employing ad­
vanced telecommunications to 
stimulate collaboration and the 
transfer of technologies re­
gardless of physical distance. 
■ It will explore various 'busi­
ness incubator' strategies, of­
fering its infrastructure and 
support services both as an en­
vironment for start­up compa­
nies and as a temporary base 
for research teams. 
■ Lastly, it will undertake a 
programme of training and 
education comprising sec­
ondment from industry, target­
ed training for industry in the 
JRC's key areas of compe­
tence, and scientific training, 
including modules on entre­
preneurship and technology 
transfer. 
Each of these activities will be 
the subject of a detailed oper­
ational study or a pilot phase 
before it is implemented in full, 
but work in all five areas will 
startin 1998. 
Together, they promise to 
bring the JRC's staff, facilities 
and technologies into closer 
contact with industrial and aca­
demic researchers, harnessing 
these unique resources to the 
cause of European competi­
tiveness. 
The JRC's core 
competences ­
addressing five 
application areas 
and based on four 
underlying generic 
technologies. 
The JRC's European 
Solar Test Installation 
­ a centre of excel­
lence in the field of 
solar energy ­ has 
always been at the 
service of European 
industry. New tech­
nology transfer plans 
are already very 
advanced. 
(1) See Special Edition of Decem­
ber 1996 
C o n t a c t ■ F. Dezeure, JRC TI. +32 2 295 9805 
Fx. +32 2 295 3565 
E­m. freddy.dezeure@cec.be 
http://www.jrc.org/study 
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Fifth Framework Programme 
In February, EU research ministers agreed to propose a bud­get of ECU 14 billion for the Fifth Research Framework Pro­
gramme (5FP), to run from 1998 to 2002. This is well short of 
the ECU 16.3 billion proposed by the European Commission 
and ECU 16.7 billion proposed by the European Parliament, 
and is less in real terms than the budget of the current Fourth 
Framework Programme. 
mission by banks and other financial institutions in Member 
States, will make financial contributions to the establishment 
of transnational joint ventures by SMEs. 
■ A loan guarantee scheme for small and newly established 
firms — SME Guarantee Facility, to be managed by the EIF, 
will share risk with national and mutual guarantee schemes 
as a way of improving access to loan finance for newly es­
tablished firms and those with fewer than 100 employees. 
Edith Cresson, Member of the Commission responsible for 
research and innovation, warned that this low figure for the 
budget sends a negative signal to European industry and jeop­
ardises certain research activities. 
Under the co­decision procedure involving the Council and 
the Parliament which is being used to adopt 5FP, the Coun­
cil's proposal is sent to the Parliament for the second read­
ing stage. 
http://www.cordis.lu/fifth/src/whatsnew.htm 
European Technology Facility 
The European Investment Fund has begun to invest the re­cently­created facility of 125 MECU which it is managing 
for the European Investment Bank (EIB). It has negotiated mi­
nority stakes in a number of venture capital funds specialis­
ing in early­stage and high technology projects. 
The EIF aims to stimulate greater venture capital activity 
outside the UK and the Netherlands, the only Member States 
with mature markets. Its choice of funds is driven by the goal 
of increasing venture capital investment in high­tech start­
ups and other innovative SMEs. Companies with fewer than 
250 employees are especially targeted. 
The European Investment Fund has strong links with the 
Commission's Innovation Financing scheme, l­TEC (see page 
15). Funds in which the EIF invests will be eligible to apply for 
participation in l­TEC. 
EIF: Fx. +352 4266 88 300 
Financial Support for SMEs 
The Council of Ministers was expected to reach a decision on 21 April on the new Growth and Employment initiative, 
adopted by the Commission with a budget of 420 MECU for 
the three years 1998­2000. It comprises three linked pro­
grammes: 
■ A risk capital scheme — ETF Start­Up, will reinforce the ex­
isting ETF (see above) by targeting smaller, mono­technolo­
gy and institute­specific funds, where risks are higher. 
■ Support for cross­border collaboration ­ Joint European 
Venture (JEV), which will be managed on behalf of the Com­
Rules for Participation in 5FP 
The proposal for a single set of rules governing participa­tion in all the specific programmes of the Fifth Framework 
Programme, adopted by the Commission in December, in­
cludes some new measures of special relevance in the con­
text of innovation and technology transfer: 
■ adjustment of the rules on dissemination and exploitation 
depending on the distance from market of the project, which 
is normally reflected in the rate of the EU's financial contri­
bution 
■ encouragement for the exploitation of results through the 
option to make exclusive agreements, under certain condi­
tions, especially when projects are close to market 
■ a requirement for the dissemination of results when the com­
mitment to exploit them is not successfully fulfilled 
■ strengthening of the role of the 'technological implementa­
tion plan' as a detailed and structured policy instrument for 
monitoring research results 
Creating Innovation 
Environments 
The Innovation Programme has announced the results of the calls for proposals of September 1997 for projects un­
der the European Networks and Services (ENS) and Region­
al Innovation action lines. 
The ENS call resulted in 74 proposals, of which 17 have been 
selected, with a further 3 on the reserve list. In total, 100 part­
ners are involved. Activities will include workshops, exchanges 
of information via appropriate communication tools, and the 
exchange and training of personnel. 
The Regional Innovation call, undertaken in collaboration 
with DG XVI (Regional Policy), covered both regional innova­
tion and technology transfer strategies and infrastructures 
(RITTS), and a new action line called Trans Regional Innova­
tion Projects, designed to support practical co­operation be­
tween European regions in the field of innovation. 
From the 101 proposals received, 42 were selected, with es­
timated EU funding of 11.2 MECU, and a further seven were 
placed on a reserve list. 
ENS: J­C. Venchiarutti, Fx. +352 4301 34544 
Regional Innovation: M. Busch, Fx. +352 4301 32100 
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► I N N O V A T I O N P R O J E C T S 
A European Technology 
Transfer Community 
The results of the third and final call for technology validation and technolo-
gy transfer projects were published mid-February. This provides an opportu-
nity to review participation in such projects under the Fourth Framework 
Programme as a whole. 
Accepted proposals by lead partner type 
National Bodies 
Public Enterprises 1 
International I 
Organisations J 
Others 
10 IS 20 > 5 0 
Number of Projects 
Large companies have led progressively more Innovation projects, 
but not nearly as many as SMEs. 
Funding has been approved for 44 projects selected 
from proposals submitted in re­
sponse to the call of June 
1997. With the Fourth Frame­
work Programme nearing its 
end, a more limited budget was 
available than for the two ear­
lier calls. Despite this, the re­
sponse was strong, with 245 
applications received. 
The majority of the selected 
projects will make a contribu­
tion to improving the interface 
between research and innova­
tion, and to promoting an 'in­
novation culture'. 
As for previous calls, suc­
cessful projects will be required 
to complete a short Definition 
Phase of up to five months. This 
will be used to develop clear fi­
nancial plans and work pro­
grammes, and to demonstrate 
the technical and financial vi­
ability of the consortia. Subject 
to successful review, projects 
will then proceed to the main 
Implementation Phase. 
K e y F a c t s 
■ Industrial interest is particu­
larly strong. 60% of the part­
ners in the 245 consortia which 
submitted proposals under the 
third call are companies, and 
43% are SMEs. 86% of con­
sortia include an SME. 
■ In the projects selected for a 
definition phase, 57% of part­
ners are companies, and 35% 
SMEs. 
■ The Innovation programme 
is clearly addressing a real 
need for academic­industrial 
technology transfer. There were 
304 universities and research 
centres among the partners in 
the applicant consortia. 
■ Taking the three calls to­
gether, a total of 1,062 pro­
posals have been received, of 
which 240 (23%) have been 
chosen to carry out a definition 
phase. 
■ To date, 68 of these projects 
(28%) have proceeded to the 
implementation phase, al­
though this number may near­
ly double by the end of 1998. 
■ Of the projects selected un­
der all three calls, the majority 
(53%) were led by SMEs. Large 
companies have led progres­
sively more projects in each 
successive call (see figure). 
■ The proportion of all select­
ed projects led by SMEs has 
fallen steadily from its high 
point of 60% in the first call, but 
remains larger than that of any 
other type under the third call, 
at 40%. 
■ Taking the three calls to­
gether, the greatest number of 
projects are co­ordinated in 
Germany, the UK, France, 
Spain and Italy. Not surpris­
ingly, the same five countries 
also submitted the largest num­
ber of proposals. 
Innovation fir Technology Transfer 
C o n t a c t ■ G. Haesen, DG XIII/D­1 
Fx.+352 4301 34129 
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THE INNOVATION 
PROGRAMME 
IN BRIEF 
The Innovation Programme 
implements the Third of 
the four Activities of the 
Fourth Framework Pro­
gramme (1994­1998). Run 
by DG Xlll/D, the Innova­
tion Programme encour­
ages the exchange of re­
search information and 
the absorption of new 
technologies by European 
companies. 
C o n t a c t ■ UnitD­1: Technology transfer 
and validation projects, 
JRC liaison, intellectual 
property 
Fx:+352 4301 34129 
■ Unit D­2: Community 
Information and 
Dissemination Service 
Fx: +352 4301 35389 
■ Unit D­3: Relay Centres 
and other services 
Fx: +352 4301 34009 
■ Unit D­4: Innovation 
policy, regional aspects, 
financing, EIMS 
Fx: +352 4301 34544 
Innovation Home Page 
Http://www.cordis.lu/ 
¡nnovation/home.html 
/ttHOtíxfatC 
'NOV 
► RESEARCH I N F O R M A T I O N 
CRIS 98: A Hard 
Nut to Crack 
Almost 200 delegates from across Europe and as far afield as Taiwan, Israel 
and the United States met in Luxembourg last March for CRIS 98, the fourth 
in a series of workshop conferences on Current Research Information Sys-
tems in Europe. 
.,.1U-„L„J ■fl 
e&isw, 
) Rwiiik laÍMulM Pruidrti 1 a S ^ ,t""?g,s «A 
— M _ 
More background informa­
tion can be found in the 
CRIS 98 Cybercafé at 
http://www.cordis.lu/ 
cris98/. The conference 
proceedings will be built 
around the Cybercafé, and 
should be published on 
CD­ROM later this year. 
α 
The CRIS 
Conference is 
α worthwhile 
investment for 
the future 
?? 
David Moore of the UK's Office of 
Science and Technology, opening 
the conference 
R esearch information sys­tems are the nutcrackers 
that offer rapid and easy ac­
cess to a wealth of research 
and technical information of 
potentially great benefit to Eu­
ropean industry", noted Mario 
Bellardinelli, Head of the Euro­
pean Commission's R&D In­
formation Service (CORDIS), 
during the conference's open­
ing address. 
The three days of CRIS 98 
saw a consensus form on a 
range of strategic priorities: 
harmonisation and standardi­
sation, user­specificity, user­
friendliness, and the need for 
good practice. Not surprising­
ly, divergent opinions emerged 
as to how ­ and how quickly ­
these priorities should be ad­
dressed. 
P o i n t s of 
D e p a r t u r e 
Keynote speaker Dominique 
Foray, currently research direc­
tor at France's Centre National 
de la Recherche Scientifique 
and a professor at the Universi­
ty of Paris­Dauphine, set the 
scene by calling for efficient, 
open and relevant knowledge­
based systems for generating, 
transforming, transmitting and 
storing information. Such sys­
tems were, he argued, a key de­
terminant of economic perfor­
mance and, as such, should be 
the priority goal of technology 
and innovation policy if optimal 
benefits are to be derived from 
cost­intensive research. 
Fellow keynote speaker Pro­
fessor Jürgen Krause, chair­
man inter alia of the German 
Academic Association for In­
formation Science and scien­
tific director of the Bonn­based 
Informationszentrum Sozial­
wissenschaften (Social Science 
Information Centre), saw four 
lines of potential development: 
■ Innovative research infor­
mation systems featuring ex­
tensive texts/facts integration 
to enable users looking for text 
documents on a specific topic 
to retrieve all data available in 
different databases; 
■ Systems which heuristically 
(i.e., by trial and error) integrate 
intellectual indexing and auto­
matic probabilistic indexing and 
retrieval, and which enable 
multilingual retrieval ­ queries 
in one language yield relevant 
documents in other languages; 
■ Visualisation systems to en­
hance user interface design; 
■ Retrieval systems able to 
cope with many different data 
sources. 
E n t e r 
t h e I n t e r n e t 
"As a result of evolving infor­
mation technology, the acces­
sibility of research information 
systems has changed sub­
stantially", said Lieve Van 
Woensel of the European Com­
mission's Innovation Pro­
gramme and coordinator of 
CRIS 98. Only a decade ago, 
research information sources 
were consulted almost exclu­
sively by specialist information 
providers. Today, these user­
friendly and easily­accessible 
information systems are con­
sulted by a vast community of 
both specialist and non­spe­
cialist end­users. As a result, it 
is essential to reappraise and 
accommodate the resultant 
changes in end­user needs." 
That access to technology­
oriented information is no 
longer restricted to a privileged 
few can be attributed to a large 
degree to the exponential 
growth of the Internet and the 
fact that dissemination and re­
trieval of information via web­
sites and dedicated search en­
gines is low­cost and ­ osten­
sibly ­ simple. 
Van Woensel and other 
speakers stressed, however, 
that the revolution in technolo­
gy transfer implicit in the ad­
vent of the Information Super­
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highway also implies new skills: 
it should not be assumed that 
the ability to focus search cri­
teria and identify appropriate 
search platforms are acquired 
virtually overnight. On the oth­
er hand, systems and pro­
grammes described and/or 
demonstrated during CRIS 98 
were clear evidence of 
progress towards an improved 
pan­European research infor­
mation environment. 
C R I S o r C r i s i s ? 
Users of research information 
are increasingly confronted at 
both the national and interna­
tional level with various kinds 
of on­ and off­line databases 
which differ substantially. "Even 
more frustrating is that many 
users do not have at their dis­
posal a complete listing of the 
international research informa­
tion systems currently avail­
able", noted Renze Brandsha 
of the Netherlands Institute for 
Scientific Information, who re­
called a 1993 survey by the 
Netherlands Agency for Re­
search Information which re­
vealed the existence of no few­
er than 92 research information 
systems worldwide. 
That was a nagging problem, 
agreed keynote speaker Keith 
Jeffery, head of information 
systems engineering in the 
computation and information 
department of the Oxford­
based Rutherford Appleton 
Laboratory (United Kingdom). 
But there are other potentially 
more serious problems that 
need immediate attention. 
"CRIS are not much used when 
compared with other informa­
tion sources ... It would be rea­
sonable to expect everyone in 
the R&D community in the 
broadest sense to access CRIS 
perhaps once or twice per 
week. At the moment we are 
not achieving such a target by 
several orders of magnitude. 
What is wrong?" 
Part of the explanation, he 
submitted, was that CRIS sup­
pliers ­ "with one or two notable 
CORDIS: 
IMPROVED U S E R FRIENDLINESS 
CORDIS, the Community R&D Informa­
tion Service (http://www.cordis.lu/) is now 
even easier to use, offering access to 
R&D Partner, Project and Results search­
es via a clickable map. 
exceptions" ­ have not moved 
with the times, persisting in the 
view that they need only pro­
vide a library­type service. Far 
from it. "At both CRIS 93 in 
Amsterdam and CRIS 95 in Mi­
lan, I argued for metadata­as­
sisted, user­friendly interfaces 
and hypermedia result presen­
tation ... If metadata describing 
the information available in an 
information provider system is 
not visible on the web, the in­
formation itself is invisible to the 
world. People do not have the 
time, energy or motivation to 
search out information from 
suppliers with arcane access 
procedures." 
For Jeffery and others, meta­
data systems hold the key in 
that they enable intelligently­
assisted querying, on­line help 
and intelligent interpretation of 
results. "Metadata helps in 
quality control and allows sys­
tems to exchange information 
or participate in global queries. 
Metadata can advertise infor­
A single mouse click on the map of 
Europe (inset) takes you to a second page, 
where search criteria can be completed 
by filling in a simple form and/or by 
selecting a particular region from a more 
detailed map of the selected country. 
C o n t a c t ■ CORDIS Help Desk TI.+352 44 10 12 2240 
Fx.+352 44 10 12 2248 
E­m. helpdesk@cordis.lu 
The CORDIS service has just completed a highly 
successful roadshow tour of Luxembourg, the UK, 
Germany, France, Italy and Belgium. The exhibition 
vehicle's many visitors were able to try CORDIS for 
themselves via on­line facilities. A further European 
Tour is planned for the autumn. 
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mation and is in every sense a 
gateway to CRIS. Metadata, in 
a word, is the future." 
Q u e s t i o n s f o r 
2 0 0 0 
"So," Mario Bellardinelli asked 
the panel discussion at the end 
of the conference, "where do 
we go from here? Have we 
made progress?" 
The response ­ from Jostein 
Hauge, secretary of the Euro­
CRIS platform ­ was positive. 
Seven years ago the first CRIS 
Conference was an achieve­
ment simply by bringing peo­
ple together from across Eu­
rope, he pointed out. Today 
there is increasing specialisa­
tion, and the focus has pro­
gressed to user needs. 
User­orientation, it was 
agreed, is now a major objec­
tive. What do the different user 
groups ­ suppliers (researchers) 
on the one hand, users (SMEs) 
on the other ­ actually need? 
Vol. 3/98 ' May 1998 
How important is multilingual­
ity? How much ­ if anything ­
should the user have to pay? 
Can CRIS be used to help the 
general public understand sci­
ence and technology ­ perhaps 
through pitching CRIS at jour­
nalists as well as companies? 
By the time the next confer­
ence is held in the year 2000, 
some of these questions will 
hopefully be answered, and 
the worlds of national R&D will 
be more transparent across 
Europe. 
C o n t a c t ■ L. Van Woensel, DG XIII/D­2 
Fx. +352 4301 34989 
lieve.vanwoensel@lux. 
dg13.cec.be 
http://www.cordis.lu/ 
cris98/ 
yi»Htfi*»/fo»C 
► I N N O V A T I O N M A N A G E M E N T T E C H N I Q U E S 
Good Practice 
Makes Perfect 
As the initiative to promote Innovation Management Techniques nears 
its end, SMEs and innovation management advisers are being offered 
opportunities to observe, discuss and absorb best practice. 
The IMT projects were de­signed to introduce im­
proved methods for the man­
agement of innovation to com­
panies not already familiar with 
them, especially SMEs. To­
gether, the projects were in­
tended to raise the standards 
of the professional support 
available to SMEs in all EU 
Member States, by identifying 
and spreading best practice. 
I n d u s t r i a l D e s i g n 
The European Design Innova­
tion Tool (EDIT) is an IMT pro­
ject which aims to improve de­
sign and innovation manage­
ment in SMEs by applying a 
new methodology based on 
C o n t a c t ■ IMTs: J. Tiscar, DG XIII/D­4 
Fx.+352 4301 32100 
Ε­m. jose.tiscar.ramirez® 
Iux.dg13.cec.be 
http://www.cordis.lu/ 
¡nnovation/src/3ba¡ int.htm 
■ EDIT: E. Wijkander, 
Swedish Industrial Design 
Foundation (SVID) 
Tl. +46 8 783 83 24 
Fx. +46 8 661 20 35 
E­m. eva.wijkander® 
svid.se 
■ ACCESS: B. Vickers, 
Pera Consulting (UK) 
Tl.+44 166 450 1034 
Fx.+44 166 450 1261 
E­m. brendan vickers® 
peragroup.com 
http://www.iwt.be/imt/ 
techniques, tools and best 
practices. The eight design pro­
motion centres which form the 
project consortium are drawn 
from seven European countries 
and are led by the Spanish 
State Agency for Design and In­
novation Development (DDI). 
A conference, to present the 
project's work to design and in­
novation policy­makers, na­
tional design centres, Innova­
tion Relay Centres and others 
involved in design associations 
and consultancies, will be held 
in Stockholm on 8 June. 
Conference sessions will in­
clude: 
■ an introduction to the EDIT 
methodology 
■ discussion of the integration 
of industrial design into R&D 
projects 
■ a review of activities to 
strengthen competitiveness in 
the field of industrial design, in­
cluding the co­ordination of 
support organisations in differ­
ent European countries 
S t a t e of t h e 
I M T A r t 
Promotion and co­ordination 
of the Europe­wide delivery of 
IMTs is the aim of the ACCESS 
project. It has created a Euro­
pean network of IMT providers, 
produces a regular newsletter, 
and has organised a series of 
transnational conferences and 
workshops, as a forum for the 
exchange of experience from 
projects funded under the In­
novation Programme's IMT ac­
tion line. 
CORDIS has released a short 
video, 'Conducting the Instru­
ments of Innovation', offering a 
guided tour of the R&D informa­
tion service's main features. Of 
interest to new and experienced 
users, the video is available in 
English and French. It will soon 
be possible to view a digitised 
version on­line on the CORDIS 
server. 
A special viewing of the video during the Research 
Council meeting of 12 February in Brussels. 
The third and final ACCESS 
conference ­ to be held in 
Kensington, central London, on 
19 and 20 October ­ will focus 
on the findings of IMT projects 
from around Europe. The event 
is aimed at organisations which 
promote the use of innovation 
management techniques by 
SMEs, and delegates will be 
encouraged to present and dis­
cuss their own experiences. 
The conference will also in­
clude a session devoted to 
common features and the state 
of the art in innovation man­
agement, including presenta­
tions of the results of recent 
studies. □ 
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► DEBATING T E C H N O L O G I C A L C H A N G E 
Setting the 
for 
At*M*rt&t 
Science and technology are transforming Europe. But the tomorrow which 
new technologies bring will meet Europe's needs only if - today - the 
process of change engages the active interest of ordinary people, as well as 
of scientists and politicians. 
The Innovation Programme is helping to provide the 
tools needed to create a social 
environment in which techno­
logical change is well under­
stood and actively managed by 
all the people whom it will di­
rectly affect. Through a series 
of Training and Dissemination 
Schemes, the programme is 
encouraging the development 
and use of mechanisms for 
consultation and debate about 
science and technology. 
C r e a t i v e D ia logue 
The FLEXIMODO project 
builds on earlier work, which 
led to new methods for raising 
awareness and articulating de­
mand about technological in­
novation in the context of the 
urban environment (European 
Awareness Scenario Workshops 
- EASW). 
FLEXIMODO's focus is sus­
tainable development, and it 
has extended the workshop 
approach to offer municipali­
ties a flexible structure for dis­
cussions between citizens, 
politicians, business represen­
tatives and NGOs about the 
challenges and opportunities 
presented to their city or town 
by new technologies. 
"These groups would nor­
mally have no opportunity to 
discuss such issues. The infor­
mal workshop setting makes 
real dialogue possible," says 
Yvonne van Delft of the Inter­
national Institute for the Urban 
Environment (HUE), the pro­
ject's co-ordinator. "They may 
have very different expectations 
and fears about the impacts of 
technological change. But they 
have a shared interest in antic­
ipating and influencing that 
change, and each has a valu­
able contribution to make to the 
debate." 
Over two days, the workshop 
guides them through the iden­
tification of local problems, 
trends and possible future sce­
narios, vision-making, ideas 
generation and action planning. 
In van Delft's view, the action 
planning is critical. "Workshops 
are unlikely to produce concrete 
results if they are treated as 
one-off events," she says. 
"People find them enjoyable 
and empowering, and that cre­
ative energy needs an outlet. An 
action plan offers a clear path 
for exploration and implemen­
tation of the ideas generated." 
The workshops have worked 
particularly well where there is 
a firm commitment to follow-up. 
G o o d R e s u l t 
For each of three subjects -
mobility, information and com­
munication, and regeneration 
- FLEXIMODO offers four 
basic scenarios, which can be 
tailored to suit local circum­
stances. Forty towns and cities 
have already used the method­
ology in the framework of the 
EASW initiative. In 1996 a small 
town in Austria organised a 
workshop to consider the pos­
sible construction of a biomass 
plant. Just before she spoke 
to Innovation & Technology 
Transfer, van Delft had received 
a fax announcing that the plant 
had opened. 
FLEXIMODO itself will run 
nine workshops. The first was 
held in Sesto San Giovanni, 
near Milan, in December 1997. 
Others will be run in Portugal, 
Denmark and Spain during 
1998. Two workshop sites have 
yet to be chosen, and Ms van 
The FLEXIMODO method 
is empowering - and fun. 
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jbMJHfafali, 
From left, Peder Falk, 
Professor Lars Olson 
(head of the neurological 
department at Stock­
holm's Karolinska Insti­
tute) and Helge Skoog, in 
a scene from the Klara 
Soppteater's production 
Brainspotting. 
C o n t a c t ■ F. Fernandez, DG XIII/D­2 
Fx. +352 4301 35389 
Ε­m. francisco.fernandez® 
Iux.dg13.cec.be 
http://www.cordis.lu/ 
innovation/src/tds.htm 
■ FLEXIMODO: 
Y. van Delft, HUE 
TI. +31 15 262 32 79 
Fx.+31 15 262 48 73 
E­m. urban@theoffice.net 
http://www.idis.unina.it/ 
f leximodo/f leximodo.html 
■ European Theatre of 
Science: H. Skoog, Stock­
holms Stadsteater AB 
Tl.+46 8 506 20 100 
Fx. +46 8 506 20 364 
Ε­m. helena.smeds® 
stadsteatern.stockholm.se 
http://www.cordis.lu/tdsp/ 
src/estprj.htm 
Delft is keen to hear from any 
European municipality inter­
ested in organising such an 
event. 
S c i e n c e Live 
The European Theatre of Sci­
ence project (ETS) is develop­
ing another novel way of im­
proving public understanding 
of science ­ by getting top 
scientists to appear live on 
stage. 
The Klara Soppteater, part of 
the Stockholm City Theatre, 
has worked with the Swedish 
Council for the Planning and 
Co­ordination of Research for 
a decade. In 1988, its actors 
took part in the Council's an­
nual Popular Science Week, 
performing sketches and im­
provisations between lectures. 
They went on to develop a full­
length production ­ The Gene 
Scene', which deals with 
biotechnology. 
In this and five subsequent 
productions, well­known sci­
entists perform alongside the 
actors. Helge Skoog, the co­
ordinator of the ETS project, 
calls it a cross between theatre 
and scientific lecture. 
"As actors, we can ask the 
naïve questions which mem­
bers of the audience might not 
dare to ask. ETS encourages 
scientists to climb down from 
the ivory tower and confront 
the concerns of ordinary peo­
ple," he says. "It is about 
democracy. Biotechnology, for 
example, raises important so­
cial issues!1). People need to 
discuss its social and environ­
mental impacts, so it is vital 
that they have some grasp of 
the underlying science." 
On T o u r 
Not all scientists would be 
willing to appear on stage, but 
Skoog has found ones who 
are. "They love it," he says. 
"They see the value of explain­
ing science to the public. And 
they have a surprising talent for 
stand­up comedy." 
The six plays are in repertory 
at the Soppteater's daily 
lunchtime show. Covering the 
universe, the greenhouse ef­
fect, food and health, evolution 
and the human brain in addi­
tion to biotechnology, they are 
regularly sold out. 
The other two ETS partners 
are also established compa­
nies. Spectrum Drama and 
Theatre Projects is the resident 
company of the London Sci­
ence Museum, and specialis­
es in science theatre for edu­
cation. With a team of over 40 
actors, it tours its ground­
breaking work to museums and 
schools throughout the UK. 
Amsterdam's Pandemonia 
Science Theatre has created 
over 50 productions since 
1988. Supported by Stichting 
WeTeN, the Dutch Foundation 
for Public Understanding of 
Science, it has strong links with 
the Dutch business and sci­
ence communities, and per­
forms regularly in schools, mu­
seums and universities. 
Each company has a different 
emphasis and approach, but all 
three are keen to spread the 
idea of science theatre. They 
are jointly developing best 
practice guidelines, supported 
by a manual and an on­line 
database of scripts and back­
ground materials, and are cre­
ating a European network to 
ensure on­going dissemination 
of their methods. 
And they will tour Europe to 
promote their work. "We will in­
vite actors, scientists, museum 
staff, teachers and science 
journalists to join us in a two­
day science theatre workshop," 
says Skoog. "Our aim is to help 
them to get to know one an­
other, and to share our enthu­
siasm for this new way of pro­
moting science." □ 
(1) See this edition's Dossier, pages 
16­21 
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► IRC CASE STUDY 
Visualising the 
Impact of Ceramics 
The Italian Innovation Relay Centre ENEA/IRENE has helped the ceramics industry by overseeing 
the development of an elegant multi-purpose software package that takes the trouble out of tiling. 
Ceramic tiles make a perfect covering for bathroom and 
kitchen floors and walls. Many 
people choose patterned tiles, 
often with a complex design. 
The visual effect can be stun­
ning, but selecting and arrang­
ing the tiles can be difficult and 
time-consuming. Enter a new 
computer system, which cre­
ates a 3-D simulation of the 
room, allowing the owner to vi­
sualise the effect of tiling with 
many different designs. 
The Decorazione E Ambien-
tazione (Design and Arrange­
ment), or DEA, system is mod­
ular, and versions are available 
for all major computer systems. 
Tile manufacturers can use it to 
assemble a comprehensive 
electronic catalogue for their 
retailers, enabling customers 
to see a far greater number of 
designs. Marketing support 
software uses a two- or three-
dimensional CAD (Computer-
Aided Design) system to simu­
late the finished floor and wall 
arrangements in a scale mod­
el constructed using the cus­
tomer's own measurements. 
M a r k e t A c c e s s 
DEA was originally conceived 
by ENEA, the Italian national 
agency for research and inno­
vation, which had worked on 
computer applications in the 
Italian textiles industry. It put 
together a large team to trans­
fer similar technology to the ce­
ramics sector, with the aim of 
encouraging local tile manu­
facturers to expand into Euro­
pean markets. 
Beautiful bathrooms - DEA in action 
Assopiastrelle, the Italian tile 
manufacturers' association, 
was involved in both system 
specification and distribution 
to potential customers. ENEA 
also brought in the Italian 
graphic designers' association, 
CNA, the tile retailers associa­
tion, Federcomated and the 
Emilia-Romagna regional de­
velopment corporation, Ervet 
(Politiche per le imprese) SpA. 
Ervet itself acted as an inter­
face with local end-users, but 
it was soon clear that the tech­
nical expertise available local­
ly would not be sufficient to 
meet demand, and that the 
project needed outside help. 
Andriana Zini of Ervet says that 
ENEA was critical in building 
the partnership. "It was able to 
bring in the Spanish computer 
firm EMC Consultores SA and 
Interaction, the Rhône-Alpes 
regional development technol­
ogy agency. ENEA also played 
a vital role in securing EC fund­
ing and in drafting the partner­
ship agreements." 
The partners started by defin­
ing a standard for the electronic 
catalogues. ENEA, Ervet and 
Assopiastrelle then produced 
software which would enable 
any company to build and 
maintain its own catalogue. The 
system was evaluated by large 
tile manufacturers before small­
er users in Italy, France, Spain, 
Portugal and Greece used ear­
ly versions in a pilot scheme. 
P r o m o t i n g D E A 
ENEA has promoted DEA to 
tile manufacturers and distrib­
utors, and has established a 
marketing network in Italy and 
abroad. Ervet has organised 
presentations at exhibitions in 
places as widespread as 
Bologna, Miami, Berlin and Va­
lencia. 
The DEA software is selling 
well throughout Europe, South 
Africa, Australia, South Ameri­
ca and East Asia. Software and 
documentation are available in 
English, Spanish and German, 
and translations into French, 
Greek and Portuguese are in 
progress. ENEA has recently 
set up new marketing agree­
ments to sell DEA in Japan, 
Singapore, Korea, China, and 
Scandinavia. 
ENEA has also established an 
Internet site for DEA. It contains 
details of the different products 
available, examples of images 
and designs and downloadable 
demonstrations of some of the 
software. □ 
C o n t a c ■ R. Buonamici, ENEA/IRENE 
Tl.+39 51 6098 197 
Fx. +39 51 6098 084 
¡rene@risc990.bologna. 
enea.it 
http://risc590.bologna. 
enea.it 
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► I N N O V A T I O N P R O J E C T 
Growing 
Intelligence 
The Single Market presents a huge opportunity to producers of top-quality 
fruit and vegetables, and a serious threat to less careful growers. Using pre-
dictive models, new weather monitoring networks will help Mediterranean 
farmers to improve quality - and to use fewer chemical sprays. 
Standing at the top of the vineyard, the old man wrin­
kles his nose and looks off into 
the early morning mist. 
"It is time to spray again," he 
says. "I can feel the mildew 
coming." 
"No, father. I have just logged 
on to the network, and the threat 
is small. We should wait for a 
spraying recommendation." 
"Oh, your expensive toys. I 
have been farming here for over 
40 years, you know." 
But after three years of fol­
lowing the computer's advice, 
the farmer is coming to appre­
ciate it. The farms which have 
clubbed together to invest in 
the monitoring system spray 
less frequently than their neigh­
bours, which saves money. But 
their vines are disease-free. 
Grape quality and yields are up, 
and profits - well, profits have 
never been so good. 
"I would like you to take over 
the farm next season," he says 
suddenly. 
P r e c i s i o n F a r m i n g 
Austrian company Adcon 
Telemetry's AgroExpert dis­
ease forecasting system has 
been used in parts of northern 
Europe for as long as five 
years. It employs a network of 
solar-powered weather stations 
to monitor rainfall, temperature, 
humidity, wind speed and oth­
er factors, over a range of up to 
100 kilometres. 
Every 15 minutes, data is 
transmitted by radio to a PC at 
the base station, where it is 
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T/>e predictive mod­
elling software is 
easy to use, and 
runs on inexpensive 
PCs. 
compared with a mathematical 
model of the conditions which 
favour attack by a specific dis­
ease. The system issues a rec­
ommendation to spray at the 
precise moment when the 
chemical will be most effective. 
Farmers may be contacted by 
phone or pager, or can access 
the system directly via a PC 
and modem. 
"There are installations in Ger­
many, France, the UK and Aus­
tria," says Bernd Hartmann of 
Adcon, the co­ordinator of the 
Innovation project TOCAP 
South. "We have developed 
models for diseases which do 
tremendous damage to crops 
such as apples, tomatoes, pota­
toes, sugar beet and grapes." 
The northern European expe­
rience is that disease forecast­
ing based on accurate climat­
ic data boosts farm profits and 
Innovation & Technology Transfer 
reduces environmental im­
pacts. "In most years, German 
vineyards which use the sys­
tem to protect against the 
mildew Peronospara have ap­
plied fewer chemicals," Hart­
mann says. "The manufactur­
er might specify eight applica­
tions per season, while AgroEx­
pert might recommend only 
five. That is a huge saving." 
Costs are not always lower. 
In difficult years, more spray­
ings than normal may be rec­
ommended. But quality and 
yield are always maximised, at 
minimum cost, giving farmers 
a big competitive advantage. 
"This is precision farming," 
says Hartmann. "It is good for 
the farmer, good for the envi­
ronment, and good for the con­
sumer. German wine produc­
ers have even started to ad­
vertise their use of the system." 
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C l i m a t e of 
C h a n g e 
TOCAP's aim is to introduce 
this technology to southern Eu­
rope for the first time. The pro­
ject's end­users are large farms 
­ two in Sicily and two in Spain. 
"Most farming in these areas 
is very traditional, with plots of 
just 1­5 hectares, and farmers 
tend to be sceptical," Hart­
mann explains. "We chose to 
work with innovators, who are 
already producing for interna­
tional markets. They can afford 
to invest in the system, and 
have most to gain from using 
it. But we hope that when 
smaller growers see that it re­
ally works, they will join to­
gether to set up community 
networks." 
Local technology relay cen­
tres (TRCs) ­ Agricultural Data 
/MiØWlfoit 
Management Sri in Sicily and 
Inforural in Spain ­ each with 
considerable expertise in farm 
sector software development, 
will manage the installation and 
validation of the pilot networks, 
and will disseminate project re­
sults across the two regions to 
stimulate take­up. 
The two­year project was 
launched in June 1996. The 
networks were quickly installed, 
and by spring 1997 operators 
had been trained. The second 
phase spanned the 1997 grow­
ing season. Weather data was 
monitored at each site, and the 
farmers followed the applica­
tion advice generated by exist­
ing models, comparing results 
with those of the standard 
spraying regimes employed by 
neighbouring farms. 
In Sicily, even in this first year, 
small savings on chemicals 
were achieved. "The farmers 
were delighted," Hartmann re­
Installing one of the 
wireless, solar­powered 
monitoring stations in a 
sugar­beet field in Spain. 
Installation is quick 
and easy. 
calls. "But our real aim was to 
validate the models, adjusting 
parameters to suit local condi­
tions. This would normally take 
up to four full seasons. Unfor­
tunately, the project ends in 
June, half way through the sec­
ond season." 
The project's final phase ­ full 
local validation of existing mod­
els, and development of new 
models for diseases specific to 
the Mediterranean climate ­ will 
be completed, although in part 
outside the funded period. Ad­
con has provided the TRCs with 
software which will enable them 
to develop and maintain their 
own models. In due course, ir­
rigation management modules 
can easily be added. C o n t a c ■ B. Hartmann, Adcon Telemetry 
GmbH 
Tl. +49 6321 482630 
Fx. +49 6321 482631 
E­m. info@adcon.at 
http://www.adcon.com 
I N N O V A T I O N F I N A N C I N G 
From Strength to Strength 
l­TEC, the Innovation Programme's Innovation and Technology Equity Capital pilot project, 
is expanding the number of its participating venture capital funds. 
The selection of new member 
funds in Belgium, Sweden, 
Denmark and the UK brings the 
total number to 13, and further 
growth is expected soon. 
The European Investment 
Fund (EIF) will invest in the se­
lected funds from a facility of 
75 MECU earmarked for early 
stage investment in techno­
logically innovative SMEs. 
l­TEC, meanwhile, will con­
tribute up to 0.5 MECU per 
fund to the costs of appraising 
and managing such invest­
ments (1). Established funds 
must increase their holdings in 
this type of project by 50%, 
while new funds commit 25% 
of their total capital. 
I f t h e C a p F I T s 
The Innovation Programme 
also plans to launch a call for 
tenders for the Financing, In­
novation and Technology (FIT) 
project in May or June. This has 
been designed to address a 
major obstacle to the financing 
of new technology based firms 
(NTBFs) ­ the poor mutual un­
derstanding and paucity of sus­
tained links between investors 
and the innovation and tech­
nology community. 
The project will focus on the 
key themes of guarantee 
mechanisms, technology ap­
praisal methods, and the role 
of informal investors. In relation 
to each theme the project will 
comprise: 
■ survey and analysis of ex­
perience and good practice in 
establishing and maintaining 
such links, in Europe and be­
yond 
■ workshops to bring togeth­
er venture capitalists, NTBF en­
trepreneurs and policy makers 
■ structured dissemination 
to promote good practice □ 
(1) See editions 6/97 (Dossier: Fi­
nancing Innovation in Europe) and 
1/98. 
C o n t a c t ■ M. Verlinden, DG XIII/D­4 
Fx. +352 4301 34544 
Ε­m. marc.verlinden® 
Iux.dg13.cec.be 
http://www.cordis.lu/ 
innovation/src/3baf int.htm 
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Biotechnology 
To date, Europe has largely failed to convert its world­class bio­
science into world­beating commercial biotechnologies. But 
there are signs that the situation is improving. 
T he failure to commercialise scien­tif ic achievements has been called the European Paradox 0), 
and in the sphere of biotechnology it is 
no illusion. New technologies emerging 
from universities and research institutes, 
and the new companies formed to 
develop them, are bought by multi­
nationals and exploited elsewhere ­
commonly in the United States. 
Certainly, this is not always the case. 
But why does it happen so often? What 
prevents Europe from reaping the eco­
nomic and employment rewards of its 
own inventiveness? 
In summary, the principal obstacles 
faced by biotechnology in Europe are: 
■ uncertainty and lack of transparency 
in the regulatory framework 
■ problems of public perception, involv­
ing concern over ethical and health 
issues 
■ a high level of aversion to risk among 
European investors 
■ a lack of entrepreneurial motivation 
and skills at the industrial­academic 
interface 
/. Life, But Not As We Know It 
Biotechnology is not new, but today presents Europe with one 
of its greatest opportunities to achieve sustainable, 
high value­added economic growth. 
Table 1: Specialist biotech companies ­
US/Europe comparison 
Europe 
Turnover (MECU) 
R&D expenditure (MECU) 
Number of companies 
Employees 
US 
Turnover (MECU) 
R&D expenditure (MECU) 
Number of companies 
Employees 
1995 
1,471 
1,252 
584 
1 7,200 
1995 
10,160 
6,160 
1,308 
108,000 
1996 
1,721 
1,508 
716 
27,500 
1996 
11,680 
6,320 
1,287 
118,000 
source: 
growth 
17% 
20% 
23% 
60% 
growth 
15% 
3% 
­2% 
9% 
Ernst & Young BioBusiness 
(1) See page 4 
It is thousands of years since we har­
nessed yeasts and other micro­organisms 
to make beer and wine, bread, cheese 
and yoghurt, and learned to breed selec­
tively to improve the quality and yield of 
useful plant and animal species. Modern 
techniques have vastly increased the 
speed with which nature can be per­
suaded to serve human ends, and great­
ly extended the range of activities in 
which biotechnology can be applied. 
Today, it is again revolutionising agri­
culture and food production. But it is 
also producing dramatic breakthroughs 
in the treatment of disease, and offer­
ing new ways to reduce and clean up 
environmental pollution. There are few 
industrial sectors which are not either 
dependent on biotechnology as a 
source of innovation and growth 
already, or likely to become so in the 
next century. 
Cultural Revolution 
Biotechnology may be as old as 
human culture, but the explosion of sci­
entific achievement, products and 
processes, and company formation and 
employment is relatively new. 
It is only 22 years since Cenentech, 
the first successful biotech company, 
was founded. By 1996, there were 
1,300 specialist biotechnology compa­
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Is the Tide Turning 
in Europe's Favour? 
Case Study 
BioSensation! 
Opening the way for the expansion of biosensors into industrial applications. 
A biosensor converts the reaction of a 
biological molecule to a target chemical 
into a measurable electrical current. The 
greater the concentration of the sub­
stance under study, the more electrons 
flow between the system's biochemical 
and microelectronic components, and 
the higher the reading given. 
In time, the technology will offer 
rapid, highly sensitive and relatively 
inexpensive detection and monitoring 
instrumentation for a wide range of 
medical, environmental and industrial 
applications. 
Nano-sandwich 
"A biosensor generally has several lay­
ers," says Dr Tim Gibson of British uni­
versity spin-off company Applied 
Enzyme Technology Ltd. "On top is an 
enzyme which reacts specifically to one 
compound. At the bottom is an elec­
tronic transducer. Between them, trans­
ferring electrons from one to the other, 
sits a second enzyme which acts as a 
mediator. There are two principal chal­
lenges - to stabilise the primary 
enzyme, and to improve the efficiency 
of the mediator at the enzyme-trans­
ducer interface." 
Today, the most successful biosensors 
available commercially are disposable 
glucose sensors, used by diabetics to 
test their blood-sugar level. The enzyme 
they employ, glucose oxidase, is inher­
ently stable. But those needed to detect 
other compounds, such as alcohol, fruc­
tose or choline, have not yet been suc­
cessfully stabilised outside the laborato­
ry. The goal of the Biotech project Dia­
monds, which Gibson co-ordinates, is to 
The three-dimensional structure of 
the horseradish peroxidase enzyme, 
mapping its electrostatic surface 
potential. Negatively charged areas 
are shown in red, and positively 
charged in blue. Part of the surface 
has been cut away to reveal the 
heme group. The molecule will be 
orientated to bring the protein main 
chain (yellow) as close as possible to 
the surface of the biosensor's elec­
tronic transducer. 
develop the basic technologies needed 
for commercial production of biosensors 
for a much wider range of uses. 
The partnership includes six research 
institutions and a German SME, electro­
chemical instrument manufacturer 
Trace Analysensysteme GmbH. AET's 
own expertise is in protein stabilisation, 
and Gibson is confident that its patent­
ed methods can deliver stability, manu-
facturability and efficiency in commer­
cial products. 
"We are now focusing on the second 
challenge," he explains. "We are study­
ing the 3-D structure of mediators such 
as horseradish peroxidase, and of the 
materials used for the transducer sur­
face - gold, carbon and highly doped 
polycrystalline silicon (HDPS), a material 
developed by the Nanometer Consor­
tium Group in Lund, Sweden. We have 
to manipulate the peroxidase molecules 
to create a close and permanent hand­
shake with the transducer, so that they 
can exchange electrons efficiently." 
Fast Food 
Dr Gibson emphasises that the pro­
ject's goal is to understand and control 
the fundamental structures and 
processes. "Product development will 
follow, once we have developed new, 
patentable interfaces," he says. "But a 
number of food industry giants are tak­
ing a keen interest, and we are already 
starting to think about a follow-up 
demonstration phase." 
The value of biosensors in the food 
and drinks sector is clear. At present, 
production monitoring relies upon peri­
odic sampling and laboratory analysis. 
Identifying a problem, and adjusting or 
shutting down a process, takes time. The 
Diamonds biosensor technology holds 
out the exciting prospect of on-line dif­
ferential sugar analysis, for example -
and ultimately of the automated micro-
adjustment of process parameters. 
t C o π T. Gibson, AET Ltd TI. +44 113 233 2599 
Fx. +44 113 233 2593 
E-m. t.d.gibson@leeds.ac.uk 
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nies in the US, directly employing 
118,000 people and with combined 
annual sales of nearly 12 billion ECU. In 
Europe, by contrast, just over half that 
number of companies employed less 
than a quarter as many people, and 
generated only 15% as much revenue 
(see table p. 16). 
Particularly alarming is the discrepan­
cy between European and US biotech 
R&D expenditure, with estimated total 
1996 US spending around three times 
that in Europe. Industrial investment in 
R&D averaged 4.9 MECU per company 
in the US, and just 2.1 MECU in Europe. 
Such figures must be treated with 
caution. "Biotechnology is not a sector, 
but a set of enabling technologies," 
explains Dr Mark Cantley of the OECD. 
"People define it in different ways, so 
producing comparable statistics is 
almost impossible." 
What is not in dispute is that Europe 
still lags far behind the US. But it may 
be starting to catch up. "The number 
of European biotech companies is 
growing by 30% each year," says Mike 
Ward, European editor of BioCentury. 
"National governments are putt ing 
huge effort into biotech development. 
Financial markets are being created, 
and venture capital funds are starting to 
invest in younger firms." 
Case Study 
New Heart Treatment 
An Innovation project has completed early clinical trials of a new clot-dissolving agent. 
T he immediate cause of a heart attack is not the narrowing of the coronary arteries produced by 
arteriosclerosis," says Professor Désiré 
Collen of the Centre for Molecular and 
Vascular Biology at the University of Leu­
ven. "The attack occurs when one of the 
plaques breaks open, exposing the fatty 
material beneath. In an attempt to heal 
the wound, the blood forms a clot, and 
it is this which occludes the artery, pre­
venting oxygen from reaching part of 
the heart muscle." 
Angioplasty disperses such clots 
mechanically by inflating a small bal­
loon in the blocked artery. But it must 
be performed within a few hours of the 
attack, and requires special equipment 
and trained staff. 
The alternative is drugs which dis­
solve the clot in the bloodstream. 
World-wide, thrombolytic therapy is 
used to treat over half a million patients 
each year, and according to Professor 
Collen three times as many would ben­
efit from it. "But none of the currently 
available drugs is perfect," he says. 
Better Targeting 
Clots are formed by a network of fib­
rin molecules. Thrombolytic drugs work 
by stimulating conversion of plasmino­
gen in the blood to plasmin, which dis­
solves fibrin. The most effective, Tissue-
type Plasminogen Activator (TPA), is so 
expensive that it is not much used out­
side the US. Others stimulate an 
immune response, and can only be 
used for brief periods. 
The project - supported by the Inno-
The left anterior deseen dens 
coronary artery before (above) and 
after (below) a clot was successfully 
dissolved through an infusion of 
staphylokinase. 
vation programme and co-ordinated by 
Professor Collen and Professor Behnke 
of the Hans Knöll Institute (HKI) in Jena, 
Germany - is developing a new drug. 
"We had been studying a bacterial pro­
tein called staphylokinase since 1990," 
he says, "and had found it to be a 
potent and uniquely fibrin-selective 
plasminogen activator. Instead of gen­
erating plasmin systemically it acts on 
the clot in a targeted way, so it is 
extremely efficient. With support from 
the Innovation programme, we and our 
partners have defined the Good Manu­
facturing Practice (GMP) procedure 
needed for approval by the European 
authorities, and are developing the 
methods for large-scale production." 
European Patent 
Initial clinical trials involving 300 
patients were successful, US and EPO 
patents have been issued, and produc­
tion facilities have been established at 
HKI. Collen is certain that the new drug 
could not have reached this stage so 
quickly in any other way. "A large phar­
maceutical company could not have 
done it," he says. "And our consortium, 
which consists of a university laborato­
ry, a small university spin-off company, 
and a research institute, was only able 
to do so with EU funding." 
The decision to go ahead with a full-
scale efficacy study when the project 
ends in June has not yet been taken. 
This would involve comparative trials 
involving 10,000 patients, and would 
require a large injection of venture capi­
tal or the sale of a license to exploit the 
technology. The partners may instead 
develop less immunogenic versions of 
the staphylokinase treatment, whose 
effectiveness they have already demon­
strated in pilot studies. 
In either case, improved treatment for 
the victims of heart attacks is likely to be 
available early in the next century. 
C o n t a c t D. Collen, Centre for Molecu­lar and Vascular Biology, 
KU Leuven 
Tl. +32 16 34 57 72 
Fx. +32 16 34 60 01 
Em. desire. collen@med. kuleuven. 
ac.be 
Innovation & Technology Transfer 18 Vol. 3/98 · May 1998 
DOSSIER! 
The scope for further technological 
and commercial innovation is enor­
mous, and with Europe leading the way 
in massive cornerstone projects such as 
the sequencing of the yeast Bacillus 
subtilise) and Arabidopsis thaliana 
genomes, the future looks bright. 
Elixir of Youth 
It is not in Europe's long-term inter­
ests to raise expectations unduly, how­
ever. It took the US biotech sector five 
years to recover from the collapse of 
early enthusiasm in the equity markets. 
UK biotech firms still find it hard to 
raise money after a similar collapse in 
1995. With attention now switching to 
mainland Europe there is a danger that 
history may repeat itself in Germany 
and France. 
Dr Helma Hermans, secretary to three 
of the Industrial Platforms (IPs) associat­
ed with the EU's Biotech programme, 
agrees. "Biotechnology is hugely 
important, and its importance wil l 
grow. But treating it as a growth indus­
try is misleading. A few companies will 
thrive as biotech specialists. But the 
larger opportunities lie in the applica­
tion of biotechnologies by established 
companies in existing industries." 
The importance of biotech start-ups is 
not so much as a source of employ­
ment and growth themselves, Hermans 
believes, but as suppliers of research 
expertise to large manufacturers of con­
sumer products. "To survive, big com­
panies must continuously renew their 
products and processes," she says. "But 
they are not nimble enough to under­
take all the research themselves. To stay 
profitable, they need regular injections 
of top-quality new technology, and get 
them by investing in start-up research 
firms whose results are commercially 
promising." 
But the market for new technologies 
is global. Corporate investment in Euro­
pean biotech R&D already exceeds 
public expenditure, but it could be far 
higher. In 1995, Europe's pharmaceuti­
cal giants alone invested more than 
3 billion ECU in US biotechnology firms. 
Context 
Biotechnology: 
The Issues 
(2) See edition 6/97 
What is biotechnology? 
Definitions vary. The word refers to 
any technique using naturally occurring 
organisms, their cells and their prod­
ucts, to create useful substances or 
effects. The OECD calls it "the applica­
tion of scientific and engineering princi­
ples to the processing of materials by 
biological agents". It draws on scientific 
expertise in the fields of biology, bio­
chemistry, genetics, microbiology and 
biochemical engineering. Recombinant 
DNA technology, one of biotechnolo­
gy's basic tools, uses enzymes to 
remove specific genetic information 
from one organism and transfer it to 
another. 
Does biotechnology raise special ethi-
cal issues? 
Some people believe it does. Others 
see no difference between today's tech­
niques and tradit ional methods of 
genetic manipulation - and believe that 
the costs and risks should be weighed 
rationally against the huge benefits. 
In Europe, public mistrust of biotech­
nology, far greater than that in the US, 
constitutes a real constraint on the 
commercialisation of its products. In 
practice, concern is focused on emotive 
areas such as genetic screening and 
genetically modified (GM) crops. The 
application of biotechnology in the 
search for new cancer treatments or a 
malaria vaccine is generally welcomed, 
for example. 
EuropaBio, representing industrial 
players, has recently adopted a set of 
Core Ethical Values. Individual compa­
nies are also t ry ing a more open 
approach - for example, to food 
labelling - believing that better informa­
tion may overcome consumer mistrust. 
The European Federation of Biotech­
nology has established a Task Group on 
Public Perceptions of Biotechnology, 
which is supported by the Biotech pro­
gramme, and in 1992 the Commission 
itself set up a panel of expert advisers 
on bio-ethics 0). But the polarised views 
of farmers, food distributors and con­
sumer groups continue to hamper the 
development of a clear EU policy on the 
labelling of GM foods. 
Can biotechnology Inventions be 
patented at European level? 
Not yet. There are still major differ­
ences between Member States' laws on 
the patent ing of biotechnological 
inventions. 
The Council of Ministers has recently 
agreed a common position on a pro­
posed EU Directive on patent protec­
tion. If adopted by the European Parlia­
ment, the Directive would harmonise 
national rules. Patent protection of 'dis­
coveries' such as the harnessing of nat­
urally occurring substances would not 
be possible. As a result of amendments 
already adopted by the European Parlia­
ment, cloning of human beings and 
any manipulation of genetic identity 
will be forbidden. 
The Forum for European Bioindustry 
Co-ordination (FEBC) believes that con­
t inued uncertainty about the 
patentability of some inventions will sti­
fle investment in European R&D, and 
make it hard for Europe to benefit from 
the commercial and employment 
opportunities which biotechnology 
offers. 
(I) The Croup of Advisers on the Ethical Implica-
tions of Biotechnology was replaced in February 
7 998 by the European Croup on Ethics ir 
Science and New Technologies, which will 
provide advice on ethical issues in all areas of 
science and research. 
t C o n t a c Task Group on Public Per­ceptions of Biotechnology 
http://www.kluyver.stm.tudelft.nl/ 
efb/tgppb/home.htm 
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Π. The EU: Making a Difference 
Europe must foster its world-class resources of scientific expertise. 
Europe has to build the pan-European 
infrastructure needed for large-scale 
research, and develop financial institu­
tions to support the early g rowth of 
specialist b io tech companies. But it 
must also create a business and market 
env i ronment in wh ich the results of 
pre-competi t ive research can be suc­
cessfully commercialised. 
"The US lead is largely due to a sig­
n i f i can t ly more suppor t i ve externa l 
business environment," according to a 
recent report for EuropaBio, the Euro­
pean Association for BioindustriesO). 
But while the key factors for small spe­
cialist companies are the quality of the 
science base and access to equity capi­
ta l , large ones are affected more by 
consumer attitudes, intellectual proper­
ty protection and the regulatory frame­
work, the report says. 
Case Study 
Cold Water Wash 
Enzymes secreted by Antarctic bacteria hold the key to reducing the cost of the family wash. 
E nzymes are widely used both in i ndus t r i a l a p p l i c a t i o n s and in domestic products such as wash­
ing powder. But almost all are derived 
from organisms which live at relatively 
h i gh t e m p e r a t u r e s , and w o r k best 
above 40° C. 
Reducing the temperature at which 
they operate would produce huge ener­
gy savings - washing machines would 
no longer need heating elements, for 
example. It would also allow enzymes to 
be used for the first time in low-temper­
ature applications in the food and phar­
maceutical industries, and in biosensors 
for environmental monitoring. 
The Biotech project Coldzyme, co­
ordinated by Professor Nick Russell of 
Wye College, University of London, is 
making rapid progress towards estab­
lishing the technical p lat form for the 
development of a range of new prod­
ucts and processes. 
Frozen but Flexible 
Sea-ice below Mount Melbourne, 
Edmonson Point, Antarctica 
3-D computer simulation of 
O. -amylase. 
Bacteria living in Antarctic sea-ice 
secrete enzymes like (X-amylase, 
which degrade starch for biotechno 
logical processing at low tempera­
tures. 
Crystal of (/amylase used for 
x-ray diffraction to determine 
3-D structure. 
" In order to carry ou t its catalyt ic 
f u n c t i o n , a p r o t e i n mo lecu le must 
remain flexible," Russell explains. "We 
are i so la t i ng and cha rac te r i s i ng 
enzymes secreted by bacteria collected 
in the Alps and Antarct ica. They are 
folded in such a way that they stay flex­
ible at temperatures at which those pro­
duced by normal bacteria stop working. 
If we can find out how, we will be able 
to engineer low- temperature activity 
into other enzymes." 
The project's partners are also study­
ing the cold-loving bacteria themselves, 
with a view to using them as 'cell facto­
ries' to p roduce large quant i t ies of 
g e n e t i c a l l y - e n g i n e e r e d co ld -ac t i ve 
enzymes. 
Lastly, Russell expects their work to 
lead to novel biotechnologies. "Certain 
enzymes show new specificities when 
operated cold," he explains. "For some 
compounds, specific isomers could be 
produced by running bio-transforma­
tions at lower temperatures, changing 
or improving the purity of the product." 
Coldzyme has already succeeded in 
crys ta l l i s ing enzymes tha t degrade 
starch and protein. Unilever, one of the 
project's industrial partners, is provid­
ing nuclear magnetic resonance facili­
ties used to analyse protein flexibil ity. 
But the company is undoubtedly also 
interested in this enzyme for a future 
cold-water washing powder. 
C o η t a c Ν. Russell, W y e College T I . + 4 4 1233 8 1 2 401 
Fx. +44 1233 813 140 
E m . n.russell@wye.ac.uk 
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Funding for Growth 
The European Commission's shared­
cost funding of research, and its associ­
ated initiatives in the fields of training, 
network­building and financing, are 
widely seen as vital to the development 
of European biotech. 
Though small compared to expendi­
ture by Member States, EU funding 
devoted to biotechnology has grown 
rapidly since 1982 (see Figure), and a 
total of 1.7 billion ECU is earmarked for 
life science R&D under the Fourth 
Framework Programme. The Commis­
sion has proposed a budget of 2.7 bil­
lion ECU for the life sciences area for 
the Fifth Framework Programme 
(5FP)(4). 
"Basic research and commercial 
exploitation are very closely related," 
wrote Bruno Hansen, Director for Life 
Sciences and Technologies, in the Com­
mission's Directorate­General for 
research (5). "It is vital that European 
companies can access a critical mass of 
European research which is able to 
compete on the world stage. There is 
great strength when networks of the 
best European brains collaborate on 
projects of recognised international 
importance. This is the added value 
that European research programmes 
provide." 
Dr Hermans agrees. "EU­funded pro­
jects can bring together the best scien­
tists working in a particular field. The 
Industrial Platforms enable industry to 
suggest the broad direction which this 
shared­cost basic research should pur­
sue in order to bring the greatest bene­
fits to the greatest number of European 
companies." 
Dr Tim Gibson of UK university spin­
off AET (see BioSensation!) believes the 
EU programmes have done much to 
ease the flow of new research into the 
marketplace. "They have made acade­
mic scientists realise the urgency of 
bringing these technologies out of the 
laboratory, where they can find indus­
trial application," he says. 
Biotechnology and Finance 
For many early stage biotech compa­
nies, EU funding has made the differ­
ence between survival and failure. An 
EU research contract is very exacting, 
but unlike a venture capital fund the 
Commission does not demand a 50% 
stake in the company and a 25­30% 
Growth of EU Shared­cost 
Biotech Research Funding 
186 
15 
BEP: 
I 1982­8S 
100 
lFP(BAP): 
1985­89 
2FP (BRIDGE): 
1990­94 
3FP (Biotech 1): 
1992­94 
4FP (Biotech 2): 
1994­98 
Specific EU 
funding of 
biotech R&D 
has grown 
rapidly since 
1982. 
return on its investment. 
Venture capital is still badly needed, 
however, and can be painfully hard to 
attract. "In the US, investors accept fail­
ures, confident that they will come out 
ahead in the long term. But in Europe," 
Gibson complains, "neither venture 
capital nor private investors are willing 
to look at anything with less than a 
90% chance of success. They would 
rather put their money into mechanical 
diggers." 
The creation of pan­European finan­
cial markets such as EASDAQ will make 
the re­financing of established biotech 
companies easier. But in a joint initia­
tive with the European Association of 
Securities Dealers (EASD), the Commis­
sion has recently set up the Biotechnol­
ogy and Finance Forum (6), to improve 
the access to capital of young biotech 
firms, and to promote better under­
standing between scientists and finan­
cial institutions. 
The Forum should help biotech 
researchers and campus companies to 
adopt a more business­oriented 
approach, and to achieve better capital­
isation. Its first conference, which takes 
place mid­May in Brussels (7), will bring 
together industrialists, researchers, 
Member States and the financial com­
munity for presentations by individual 
biotech companies, and to review 
trends and examine regional experi­
ence. 
Patently Frustrating 
The Commission's role as coordina­
tor and intermediary is vital. But prob­
lems remain, and it has attracted criti­
cism for prolonging uncertainty over 
the regulat ion and patent ing of 
biotechnology, at a time when clarity is 
vital (see Biotechnology: The Issues). 
Dr Hermans is deeply frustrated by 
the lack of progress. 'This is the tenth 
year of discussions about draft biotech 
patent legislation," she points out, "and 
agreement has still not been reached. 
That imposes a huge penalty on Euro­
pean firms, and severely limits Europe's 
innovation potential. Without proper 
patent protection you might just as well 
throw your research investment down 
the drain." 
"The regulation of some biotech 
applications is a mess too," she contin­
ues. "In the US, as soon as a product 
has cleared all the hurdles it is 
approved, and can be sold in every 
State. Here, the Commission and the 
Member States keep changing the 
rules. Some plant biotechnology prod­
ucts have been stuck in the approval 
process since 1995. That is why the 
biotech investments of major European 
companies are flowing to the US." □ 
(3) 'Benchmarking the Competitiveness of 
Biotechnology in Europe', Europa Bio, ¡une 1997 
(4) Thematic programme 1 : Improving the quali­
ty of life and management of living resources 
(5) In 'European Biotech 97: A New Economy', 
Ernst & Young, April / 997 
(6) See edition 1/98 
(7) 'Promoting Entrepreneurial Initiatives in 
Biotechnology', Brussels, 12­14 May 1998. Con­
tact EASD: Fx. +32 2 227 6524 Ε­m. easd@tor­
nado.be http://www.easd.com/ 
C o n t a c t S. Hogan, DC XII/E­1 Fx.+32 2 299 1860 
E­m. stephane.hogan@dg12.cec.be 
http://www.cordis.lu/biotech/ 
home.html 
http://europa.eu.int/comm/dg12/ 
biotl .html 
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PROGRAMME BRIEFING 
► ESPRIT 
Parallel Lives 
Early in 1997, the ESPRIT programme launched a network of 20 Technology 
Transfer Nodes (TTN) across Europe, to promote the take-up of High-perfor-
mance Computing and Networking (HPCN) technology, especially among 
SMEs. A year later, the initiative is bearing its first fruit. 
H PCN, or parallel comput­ing, is an established tech­
nology. But until recently the 
high cost of hardware has re­
stricted its use to large organ­
isations. Now the appearance 
of commodity multi-processor 
computers has brought pow­
erful HPCN systems within the 
reach of a much wider group of 
industrial users. 
HPCN can improve the pro­
ductivity and cost-effectiveness 
of existing operations, or pro­
vide the platform for tasks 
which were simply not feasible 
with earlier systems. Applica­
tion areas include advanced 
engineering design, product in­
spection and quality control, 
and data mining. Two TTN-me-
diated projects illustrate its po­
tential benefits for small com­
panies. 
ï) Property of Taurus Film and Joanneum Research 
The ImSpector imaging 
spectrograph (centre) 
sorts 60 crates per 
minute, according to 
the colour of the 
bottles they contain. 
On the left, an 
original frame 
from the Austri-
an film 
'Opernball'. On 
the right, the 
same frame 
restored. 
¡Mil» 
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ììllL ' ' i " Q ; ι 
ü¡ 
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C o n t a c t ■ HPCN­TTN: C. Triay, ARTTIC 
TI. +33 1 45 15 24 50 
Fx.+33 1 45 15 24 60 
E­m. hpcn­ttn@list.arttic.com 
http://www.hpcn­ttn.org 
■ FRAME: W Plaschzug, 
Joanneum Research 
TI.+43 316 876­1172 
Fx.+43 316 876­1191 
Ε­m. waiter.plaschzug® 
joanneum.ac.at 
http://www.vcpc.univie.ac. 
at/activities/projects/ 
frame/frame.html 
■ B Despas, Centrimage 
Tl. +33 1 44 37 15 15 
E.m. centrimage@com­
puserve.com 
■ SIMON: E Herrala, 
Spectral Imaging Ltd 
Tl. +358 8 551 4495 
Fx. +358 8 551 4496 
Ε­m. esko.fiérrala® 
specim.fi 
http://www.specim.fi/ 
simon/simon.html 
F r a m e by 
F R A M E 
An irreplaceable part of our 
historical and cultural heritage 
is stored on film. But like old 
books, old films deteriorate. 
They are attacked by humidity, 
mould and dust, and receive 
new scratches every time they 
are shown. The problem affects 
both classic movies and his­
torical footage stored in mu­
seums and national archives. 
Until now, however, restoration 
has been an imperfect and 
expensive manual process. 
Joanneum Research, the 
technology provider in the 
FRAME project, has developed 
a semi­automatic restoration 
system. "We wanted it to be 
capable of restoring each digi­
tised frame in a few seconds," 
explains Walter Plaschzug. 
"But although our algorithms 
work extremely well, they re­
quire a lot of computer power. 
Without HPCN, each frame 
took several minutes to 
process ­ restoration was still 
not commercially attractive to 
the media corporations which 
own the old movies." 
For the project's end­user, 
French film and video laborato­
ry Centrimage, the HPCN tech­
nology offers access to a grow­
ing market. "Hand restoration, 
both of old film and of new 
footage damaged during shoot­
ing, is an important part of our 
business," says Bruno Despas. 
"We are very hopeful that when 
FRAME finishes at the end of 
1998, the system will allow us 
to reduce our prices for the ser­
vice, opening up new markets." 
"The cost per frame will fall 
dramatically," Plaschzug con­
firms, "creating a huge demand 
for restoration. And because 
HPCN is fully scaleable, the 
system can be adjusted to fit 
any budget or to achieve any 
throughput you want." 
C o l o u r S o r t e d 
Spectral Imaging for Industri­
al On­line Sorting (SIMON) has 
installed two pilot applications 
to demonstrate the potential of 
imaging spectrometry in 
colour­related classification 
and sorting applications. 
The ImSpector spectrograph 
was developed by Finnish co­
ordinator Spectral Imaging Ltd. 
principally for industrial process 
control and quality monitoring. 
It has been used by LCG Sri in 
Italy to grade ceramic floor tiles 
according to colour and tex­
ture, and by Orbis Oy, also in 
Finland, to check the colour of 
glass and plastic bottles as 
they move down a production 
line. 
Processing the very high vol­
ume of data generated by 
spectral imaging has only be­
come possible with the advent 
of affordable HPCN. □ 
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CONFERENCES AND PUBLICATIONS 
► CONFERENCES 
R e s e a r c h and 
D e v e l o p m e n t 
M a n a g e m e n t 
3 0 S e p t e m b e r -
2 O c t o b e r , 
Avi la (Spain) 
Organised by the partners in 
the Innovation Management 
Techniques (IMT) project 
TEMAGUIDE, the conference 
wil l examine the various 
aspects of business strategy 
and alliances which can influ­
ence research and develop­
ment, technology and innova­
tion management. It wil l 
include discussion of practi­
cal problems and considera­
tion of the implications for 
R&D management. 
Topics are likely to include: 
■ working effectively in strate­
gic alliances 
■ working with technology 
suppliers 
■ smaller company perspec­
tives 
■ resource allocation and 
project evaluation 
■ reengineering an estab­
lished partnership agreement 
Contact: 
■ D Uriate, SOCINTEC 
TI. +34 4 480 0211 
Fx. +34 4 480 0391 
E­m. rdmacon@socintec.com 
■ J Butler, Manchester Busi­
ness School 
TI.+44161 275 6338 
Fx.+44161 275 6489 
E­m. j.butler@fs2.mbs.ac.uk 
http://www.techman.org/R&D 
_98.htm 
I T P S ' 9 8 ­ I n t e r n a ­
t iona l Technology 
P a r t n e r S e a r c h 
1 8 ­ 1 9 J u n e , 
N e u c h a t e l 
(Swi tzer land) 
Organised by CENTREDOC in 
collaboration with CORDIS 
and Til ­ Technology, Innova­
tion, Information, the event 
will bring Swiss companies 
into contact with potential 
business partners from 
Europe, North and South 
America, Asia, the Middle 
East and Africa. 
It aims to attract companies 
and R&D centres wishing to 
commercialise know­how or 
technologies, to sell patents, 
and to acquire or sell licences. 
Participants will be able to 
meet foreign technology 
transfer brokers in close con­
tact with industry, R&D cen­
tres and institutions from the 
respective regions of their 
countries, as well as multina­
tional corporations and ven­
ture capitalists. 
Contact: O. Barrelet, 
CENTREDOC 
TI.+41 32 720 5131 
Fx. +41 32 720 5751 
World c o n f e r e n c e 
on s c i e n c e and 
techno logy parks 
1 8 ­ 2 3 Oc tober , 
Per th (Austra l ia ) 
The theme of this 15th world 
conference, organised by the 
International Association of 
Science and Technology Parks 
(IASP), will be 'Business part­
nerships for global opportuni­
ties'. The event will address 
five main topics: 
■ commercialisation of know­
ledge 
■ developing strategies for 
regional innovation 
■ business partnerships, net­
working and globalisation 
■ economics of science parks 
■ science park case studies 
A trade exhibition, with exhibits 
from companies providing 
services and products of 
interest to science and tech­
nology­focused organisations, 
will be held in parallel. 
Contact: XV IASP World Con­
ference on Science and Tech­
nology Parks 
TI. +61 8 9291 9306 
Fx. +61 8 9291 9978 
E­m. petrconf@iinet.net.au 
http://www.techparkwa.org.au/ 
¡aspconf98/ 
l n t e r t e c h n o l o g y ' 9 8 
­ I nves tment oppor­
tun i t i es in Poland 
4 ­ 6 J u n e , Lodz 
(Poland) 
INTERTECHNOLOGY'98, an 
international trade fair on new 
technologies, innovations and 
inventions, organised with 
support from the Innovation 
Relay Centre network, will 
provide an ideal forum for the 
exploration of high­technolo­
gy investment opportunities in 
Poland. 
Featuring an extensive exhibi­
tion area, it will also include 
lectures covering: 
■ development of a technolo­
gy transfer infrastructure in 
Poland 
■ implementation of technol­
ogy transfer on different levels 
■ new possibil it ies of co­
operation between research 
and industry 
■ business and innovation 
centres: regional support to 
SMEs 
■ special economic zones 
and technology parks in 
Poland 
■ industrial design in the 
modern enterprise 
Participants will have the 
opportunity to present prod­
ucts and technologies during 
company promotion seminars 
and informal discussions. 
Contact: Hi­Tech Co. Ltd. 
TI. +48 22 823 4252 
Fx. +48 22 822 9463 
E­m. bakow@hitech.com.pl 
http://www.hitech.com.pl 
Industr ia l s t ruc tu re , 
innovation dynamics 
and technology policy 
1 6 ­ 1 7 Oc tober , 
L isbon (Portugal ) 
The conference, organised by 
the Institute for New Tech­
nologies of the United Nations 
University (UNU/INTECH) with 
EU support, provides an 
opportunity for an exchange 
of views on: 
■ the appreciative theory of 
technological change 
■ the economics of industrial 
dynamics and macroeconom­
ic growth 
■ 'systemic' views of learn­
ing, institutions and competi­
tiveness 
Papers are invited. 
Contact: Dr A. Bartzokas, 
UNU/INTECH 
TI.+31 43 350 6313 
Fx. +31 43 350 6399 
E­m. bartzokas@intech.unu. edu 
http://www.intech.unu.edu 
A C T S Mobi le 
C o m m u n i c a t i o n s 
S u m m i t 1 9 9 8 
8 ­ 1 1 J u n e , 
Rhodes (Greece) 
The annual ACTS Mobile 
Communications Summit is a 
major forum for dissemination 
of the results of European 
research initiatives, undertak­
en within the context of the 
ACTS programme, towards 
Third Generation Mobile Com­
munication Systems such as 
UMTS, MBS and WLANs, 
including their satellite com­
ponents. 
The main emphasis of the 
1998 Summit will be on the 
implementation of prototype 
communication systems, 
some of which are expected 
to be given on­site demon­
strations. 
A one­day workshop on Soft­
ware Radio Technologies will 
take place on 11 June, featur­
ing contributions from 
Europe, the US and the 
Asia/Pacific region, and end­
ing with a Round Table dis­
cussion with an international 
panel of experts. 
Contact: E. Vaivi, ACTS Mobile 
Summit '98 
TI. +30 1 686 0430 
Fx.+301 686 0312 
E­m. mobsummit98@intra­
com.gr 
http://www.intracom.gr/mob­
summit98/ 
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CONFERENCES AND PUBLICATIONS 
► P U B L I C A T I O N S 
Tra n s-E uro pea n 
networks for in te ­
grated broadband 
communica t ions 
(TEN- IBC) 
DG XIII has published a book­
let describing the results of 
trials conducted by nine 
Trans-European Networks for 
Integrated Broadband Com­
munications (TEN-IBC) pro­
jects completed in 1997. The 
trials made wide use of the 
JAMES ATM network, set up 
under the ACTS programme to 
provide the infrastructure to 
test new communications 
applications and services. 
The projects have developed a 
better understanding of 
broadband communications 
needs and barriers. Remaining 
obstacles to the development 
of advanced services are 
mostly non-technical - in par­
ticular legal issues and the 
need for re-engineering to 
benefit fully from the Informa­
tion Society. 
The booklet shows that some 
market sectors are now ready 
for such advanced services 
provided the legal issues are 
addressed, and the experi­
ences it presents will allow 
actors in the field to develop 
business plans and to imple­
ment them in a cost-effective 
manner. 
Contact: ACTS Central Office 
Fx. +32 2 295 0654 
E-m. aco@postman.dg13.cec.be 
Euroabst rac ts -
1 9 9 7 Annual Index 
CD-AB-97-007-EN-C; 10 ECU 
The Annual Index provides a 
guide to all 1,624 abstracts of 
EU scientific publications con­
tained in the six editions of 
Euroabstracts published dur­
ing 1997, searchable by title, 
author, subject area, and pro­
gramme. 
The December 1997 edition of 
Euroabstracts was the last to 
use the established format. A 
'new-look' Euroabstracts was 
launched in April, with a more 
accessible but less compre­
hensive format, grouping 
reviews of recently published 
books, magazines, CD-ROMs 
and websites thematically. 
Abstracts of all EU scientific 
publications will continue to 
be available via the CORDIS 
RTD-Publications database 
(http://www.cordis.lu/). 
N O T E 
Publications are free 
unless otherwise stated. 
If specific contact infor­
mation for obtaining a 
publication is not sup­
plied, and there is a price 
listed in ECU, then the 
publication can be pur­
chased from the sales 
and subscription office in 
your country of the Office 
for Official Publications of 
the European Commu­
nities (Eur-OP). Address­
es can be found in most 
EC publications, on the 
WWW (http://eur-op.eu. 
int/en/general/s-ad.htm) 
and by contacting Eur-Op 
(fax: +352 2929 42759). 
Society - the e n d ­
less f ront ie r 
EUR 17655, ISBN 92 828 
1187 5; 16.50 ECU 
DG XII of the European 
Commission has published 
a report presenting Euro­
pean policies for research 
and innovation in the 21st 
century, and outlining the 
general context in which 
these are being developed. 
The report, 'Society, the 
endless frontier - a Euro­
pean vision of research and 
innovation policies for the 
21st century', is currently 
available only in French, but 
English and German ver­
sions will be published 
shortly. 
It provides a basis for 
reflection on the policy 
options being put forward 
for the Community's Fifth 
Framework Programme for 
research and development 
(5FP). The authors describe 
the economic and geopoliti­
cal context in which Euro­
pean research efforts are 
evolving - in particular, the 
emergence of new powers 
in Asia. 
The report examines the 
complex and changing rela­
tionships between research 
and society and describes 
how 5FP, by adopting a new 
approach based on 'Key 
Actions', is attempting to 
ensure that Europe under­
takes the level and quality of 
research needed to achieve 
competitiveness in the glob­
al market. 
La Société, 
Ultime Frontière 
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